Navigation Links
Brain Science Institute announces license agreement to develop treatments for neurological disease

Johns Hopkins University's newly formed Brain Science Institute's NeuroTranslational Program has entered into a licensing agreement with pharmaceutical company Eisai Inc. to discover and develop small molecule glutamate carboxypeptidase II (GCPII) inhibitors.

The NeuroTranslational Program was launched in 2009 staffed with seasoned drug-discovery scientists to work side by side with Johns Hopkins faculty to help translate basic science discoveries into small molecule therapeutics.

Under the terms of the agreement, Eisai has granted the Brain Science Institute, or BSI, non-exclusive U.S. rights to use its GCPII technology to generate inhibitor molecules for diseases of the central and peripheral nervous system, including peripheral neuropathy and neurodegeneration, Alzheimer's disease, stroke, and ALS, as well as non-central nervous system diseases.

BSI will be responsible for the GCPII research, drug discovery and preclinical activities. Eisai will have an exclusive option to develop and commercialize any drug molecules generated from the collaboration, which will be led by a joint steering committee of representatives from both entities. Barbara Slusher, Ph.D., chief scientific officer of the BSI's NeuroTranslational Program, will serve as the academic lead of the steering committee, along with the NeuroTranslational Program's Director of Medicinal Chemistry Takashi Tsukamoto, Ph.D.

"We believe this collaboration will strengthen our ability to bring a novel class of compounds to patients," said Slusher.

"It is a great accomplishment for this team to announce a licensing agreement of this kind within its first year of operation," said Jeffery Rothstein, M.D., professor of neurology and co-director of the program.


Contact: Gary Stephenson
Johns Hopkins Medical Institutions

Page: 1

Related medicine news :

1. American Brain Tumor Association Recognizes Philadelphia Family Foundation With Annual Award
2. OASIS Recognized for Brain Fitness Programming
3. Carnegie Mellon research provides insight into brains decision-making process
4. Researchers discover brain tumors grow-or-go switch
5. U discovery gives insight into brain replay process
6. UW Symposium: How Disease, Therapy, Drugs and Meditation Reshape the Brain
7. iPhone Memory Aid for Scatterbrains, Aging Baby Boomers and Busy, Forgetful People
8. After a fight with a partner, brain activity predicts emotional resiliency
9. Free Brain IQ Quiz, Activities for Home “Brain-Boosting” and Seminar Offered from LearningRX Denver during National Brain Awareness Month
10. Ritalin Boosts Learning by Increasing Brain Plasticity, According to UCSF Research
11. Golf Fore Brain Cancer Research at the Barry Spiegelman Memorial Golf Classic
Post Your Comments:
(Date:11/30/2015)... , ... November 30, 2015 , ... GKhair & Tibolli ... the San Juan Beauty Show held on November 8th and 9th at the Puerto ... media personalities, hair artists, renowned beauticians and top of the line fashion journalists. The ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... provider of enterprise Time and Attendance/Workforce Management cloud-based solutions, announced today that ... Program with competencies in the Application Development, demonstrating a “best-in-class” ability and ...
(Date:11/30/2015)... , ... November 30, 2015 ... ... Inc. are pleased to announce their strategic partnership at the Radiological Society ... Transcription Service, Inc., and Winscribe, global providers of cutting-edge dictation and speech-enabled ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... product dealer. Joining more than 30 HealthPostures’ dealers located throughout the United States, ... increase the number of corporate, industrial, manufacturing and government workers and organizational leaders ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... patented products, announces the Unstoppable Swappables, a household invention that provides an economical ... $2 billion a year and is growing at 2.6%," says Scott Cooper, CEO ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... DUBLIN , Nov. 27, 2015 Research ... of the "Global Intrauterine Devices Market 2015-2019" ... --> In this report, the author ... intrauterine devices market for 2015-2019. To calculate the market ... of following type of products: Hormonal IUDs and copper ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... November 26, 2015 ... nieuwe aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie ... ) --> ... (Photo: ) ... Medisch Centrum (LUMC) blijkt ...
Breaking Medicine Technology: